EFTA Document EFTA01354448
GLDuSi 43 Henry Nicholas SOF IV - Near term pipeline As of March 31, 2018 Project Code Deal Type Region Sunrise Stage Sourcing Deal Size SOF IV Description Investment • Restructuring of 5 asset portfolio across well-known GP-led North America Exclusive Intermediated $524 million $100 million brands in the restaurant and fitness sectors with a middle-market GP that has a very strong track record • Restructuring of a portfolio of 4 remaining companies in Klein GP-led EME
Summary
GLDuSi 43 Henry Nicholas SOF IV - Near term pipeline As of March 31, 2018 Project Code Deal Type Region Sunrise Stage Sourcing Deal Size SOF IV Description Investment • Restructuring of 5 asset portfolio across well-known GP-led North America Exclusive Intermediated $524 million $100 million brands in the restaurant and fitness sectors with a middle-market GP that has a very strong track record • Restructuring of a portfolio of 4 remaining companies in Klein GP-led EME
Ask AI About This Document
Extracted Text (OCR)
Related Documents (6)
EFTA Document EFTA01463058
Initial Leads W-,Bold"&14&UMorris Initial Leads Salutation First Name Last Name Primary Phone Type Phone Business Phone Mobile Fax Email Organization Name Position/Title/Rank Street City Zip/Postal Code Net Worth Est. Investable Assets Relationship Segment Other DB Firm Relationships Initial Opportunity 5 Mr. Dillaway Ayres Cold Spring Harbor Laboratory One Bungtown Road Cold Spring Harbor 11724 100 400 Endowment/Foundation 2 Mr. New York 4 Mr. 728 Park Avenue
HOUSE OVERSIGHT 016696-Palm-Beach
November 12, 2025 release of Jeffrey Epstein documents by the House Committee on Oversight and Government Reform. Microsoft Excel Spreadsheets converted to PDF. Originals in NATIVES/001 folder
EFTA Document EFTA01354450
GLDUSI 43 Henry Nicholas SOF IV — Project Klein Exclusive deal Expected Glosing Date: June 2018 El Fund Secondary i Secondary K Single Asset Deal Seller type: Alternative funds Key investment data Transaction summary Invested Capital at dose E60-100m (US$80-120m) Number of companies 4 Discount to NAV at close >5% Strategy Mid-market buyout Gross multiple at close 1.1x Region Europe / UK 0/0 funded at close 80% Industries Business services / Healthcare services Use of
EFTA Document EFTA01463144
report1364240932058 1 GCIS Customer Number GCIS Number Customer ID Relationship Tier Estimated Relationship Net Worth Estimated Relationship Investable Assets Breadth of Client Needs (# of products) Estimated Total Revenue Potential ($M per annum) Estimated Revenue from New Business in the coming year Strength of YOUR Relationship with Customer (1-5, 1 is strongest) Relationship Segment If Relationship Segment is "Other," Describe Other If No Potential Prospect, keep relationship
FBI USAMRID Investigation
011621Anthrax Page 1 of 1446 o I 2792\-WF-222936-'-USAMRIID - \\OC o I [he followijg investigation was conducted by Special Agent (SA)_ _of the federal Bureau of Investigation (FBI) on February 24, 2005: ? The United States Army Medical Research Institute of Infectious Diseases (USAMRIID) Keycard Access records from 1998 through 2002 were queried f r v' ? ? ? scientist nd visitin scient'st both ?rom the who have p eviously been identified as visiting USAMRIID circa May 1998. ;11 available
EFTA Document EFTA01463036
Initial Leads &"-,Bold"&14&UMorris Initial Leads Lead Owner Salutation First Name Phone Type Phone Business Phone Mobile Organization Name Position/Title/Rank Zip/Postal Code 1 Paul Morris 2 Paul Morris Street Suite 601 3 Paul Morris Two Jericho Plaza Paul Morris Entrepreneur 728 5 Paul Morris Last Name Fax Email Street City State Mr. Lee Ainslee Maverick Capital Mr. Arun Alagappan Advantage Testing New York NY 10028 Mr. Paul Amorouso Oxford & Simpson
Forum Discussions
This document was digitized, indexed, and cross-referenced with 1,400+ persons in the Epstein files. 100% free, ad-free, and independent.